GOVX Stock Quote Price and Forecast | CNN

GOVX

GeoVax Labs, Inc.

Key terms

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Mar 07 8:15am ET Noble Financial Reaffirms Their Buy Rating on GeoVax Labs (GOVX) by TipRanks Mar 06 9:02am ET GeoVax Labs achieves milestone in transition to validated manufacturing system by TipRanks Mar 01 4:11pm ET GeoVax Labs files $100M mixed securities shelf by TipRanks Mar 01 8:10am ET Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE) by TipRanks Feb 29 4:08pm ET GeoVax Labs reports Q4 EPS (14.29) vs ($12.39) last year by TipRanks Feb 16 4:13pm ET GeoVax Labs Avoids Nasdaq Delisting with Reverse Stock Split by TipRanks Feb 06 9:04am ET GeoVax Labs reports interim data from Phase 2 trial of GEO-CM04S1 by TipRanks Jan 30 7:50pm ET Geovax Labs Inc trading halted, news pending by TipRanks Jan 08 9:10am ET GeoVax Labs appoints Pipas as Executive Medical Director, Oncology by TipRanks Jan 04 9:08am ET GeoVax Labs announces Gedeptin patient enrollment closure for Phase 1/2 trial by TipRanks Jan 03 9:02am ET GeoVax Labs announces issuance of Malaria vaccine patent by TipRanks Jan 02 4:12pm ET GeoVax Labs files to sell 21.13M shares of common stock for holders by TipRanks Dec 19 9:02am ET GeoVax Labs expands rights under NIH COVID-19 license to include Mpox, smallpox by TipRanks

No recent news articles are available for GOVX

No recent press releases are available for GOVX

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images

Samuel Corum/Bloomberg/Getty Images

Geopolitical strife is roiling Wall Street. Here’s what investors are watching

Donald Trump might no longer own a majority of TMTG after a new public share offering.

Joe Raedle/Getty Images

Trump stock tanks after announcing massive share sale

1040 US Individual Income Tax Return Form

Nora Carol Photography/Moment RF/Getty Images

Three ways investors can minimize their tax payments

People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.

Spencer Platt/Getty Images

Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel